BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33498795)

  • 21. Tris-heteroleptic ruthenium(II) polypyridyl complexes: Synthesis, structural characterization, photophysical, electrochemistry and biological properties.
    Bhat SS; Kumbhar AS; Purandare N; Khan A; Grampp G; Lönnecke P; Hey-Hawkins E; Dixit R; Vanka K
    J Inorg Biochem; 2020 Feb; 203():110903. PubMed ID: 31683124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization, in vitro cytotoxicity and anticancer effects of ruthenium(II) complexes on BEL-7402 cells.
    Zhang C; Han BJ; Zeng CC; Lai SH; Li W; Tang B; Wan D; Jiang GB; Liu YJ
    J Inorg Biochem; 2016 Apr; 157():62-72. PubMed ID: 26828285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles.
    Peretti E; Miletto I; Stella B; Rocco F; Berlier G; Arpicco S
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30347763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
    Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
    J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, structure, DNA-binding properties, and cytotoxicity of ruthenium(II) polypyridyl complexes.
    Liu YJ; Zeng CH; Yao JH; Wu FH; He LX; Huang HL
    Chem Biodivers; 2010 Jul; 7(7):1770-83. PubMed ID: 20658665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trans ruthenium(II) complexes with NH-bridged tetradentate symmetric and asymmetric polypyridyl ligands.
    Concepción J; Just O; Leiva AM; Loeb B; Rees WS
    Inorg Chem; 2002 Nov; 41(23):5937-9. PubMed ID: 12425616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A theoretical study of Ru(II) polypyridyl DNA intercalators structure and electronic absorption spectroscopy of [Ru(phen)2(dppz)]2+ and [Ru(tap)2(dppz)]2+ complexes intercalated in guanine-cytosine base pairs.
    Ambrosek D; Loos PF; Assfeld X; Daniel C
    J Inorg Biochem; 2010 Sep; 104(9):893-901. PubMed ID: 20554006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
    Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
    J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA binding, photocleavage, antimicrobial and cytotoxic properties of Ru(II) polypyridyl complexes containing BOPIP ligand, (BOPIP = {2-(4-(benzyloxy) phenyl)-1H-imidazo [4,5-f] [1,2]phenanthroline}).
    Gopu S; Ravi Kumar V; Laxma Reddy K; Venkat Reddy P; Sirasani S
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(5):349-373. PubMed ID: 30890029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA-binding, topoisomerases I and II inhibition and in vitro cytotoxicity of ruthenium(II) polypyridyl complexes: [Ru(dppz)2L](2+) (L=dppz-11-CO2Me and dppz).
    He X; Jin L; Tan L
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():101-9. PubMed ID: 25062055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-binding, cytotoxicity, cellular uptake, apoptosis and photocleavage studies of Ru(II) complexes.
    N Deepika ; C Shobha Devi ; Y Praveen Kumar ; K Laxma Reddy ; P Venkat Reddy ; D Anil Kumar ; Surya S Singh ; S Satyanarayana
    J Photochem Photobiol B; 2016 Jul; 160():142-53. PubMed ID: 27107334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of an anticancer organoruthenium complex as the guest and polydiacetylene-coated fluorogenic nanocarrier as the host: engineering nanocarrier using ene-yne conjugation for sustained guest release, enhanced anticancer activity and reduced
    Sumithaa C; Gajda-Morszewski P; Ishaniya W; Khamrang T; Velusamy M; Bhuvanesh N; Brindell M; Mazuryk O; Ganeshpandian M
    Dalton Trans; 2024 Jan; 53(3):966-985. PubMed ID: 38054338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular uptake, cytotoxicity, apoptosis, DNA-binding, photocleavage and molecular docking studies of ruthenium(II) polypyridyl complexes.
    Srishailam A; Kumar YP; Venkat Reddy P; Nambigari N; Vuruputuri U; Singh SS; Satyanarayana S
    J Photochem Photobiol B; 2014 Mar; 132():111-23. PubMed ID: 24607611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells.
    Lai SH; Li W; Yao JH; Han BJ; Jiang GB; Zhang C; Zeng CC; Liu YJ
    J Photochem Photobiol B; 2016 May; 158():39-48. PubMed ID: 26945645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and photophysical properties of rare-earth complexes encapsulated into surface modified mesoporous silica nanoparticles.
    Malba C; Sudhakaran UP; Borsacchi S; Geppi M; Enrichi F; Natile MM; Armelao L; Finotto T; Marin R; Riello P; Benedetti A
    Dalton Trans; 2014 Nov; 43(43):16183-96. PubMed ID: 24874265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Spectral Properties and DFT Calculations of new Ruthenium (II) Polypyridyl Complexes; DNA Binding Affinity and in Vitro Cytotoxicity Activity.
    Mallepally RR; Chintakuntla N; Putta VR; K N; Vuradi RK; P M; S SS; Chitumalla RK; Jang J; Penumaka N; Sirasani S
    J Fluoresc; 2017 Jul; 27(4):1513-1530. PubMed ID: 28432633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of the DNA-[Ru(tpy)(dppz)(CH(3)CN)](2+) conjugates and their photo cross-linking studies with the complementary DNA strand.
    Ossipov D; Gohil S; Chattopadhyaya J
    J Am Chem Soc; 2002 Nov; 124(45):13416-33. PubMed ID: 12418893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and evaluation of anticancer activity of ruthenium (II) polypyridyl complexes.
    Tang B; Wan D; Lai SH; Yang HH; Zhang C; Wang XZ; Zeng CC; Liu YJ
    J Inorg Biochem; 2017 Aug; 173():93-104. PubMed ID: 28511064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.